Higher TLR7 Gene Expression Predicts Poor Clinical Outcome in Advanced NSCLC Patients Treated with Immunotherapy

Immune checkpoint inhibitors (ICIs) have revolutionized the treatment of lung cancer. However, their clinical benefit is limited to a minority of patients. To unravel immune-related factors that are predictive of sensitivity or resistance to immunotherapy, we performed a gene expression analysis by...

Descripción completa

Detalles Bibliográficos
Autores principales: Baglivo, Sara, Bianconi, Fortunato, Metro, Giulio, Gili, Alessio, Tofanetti, Francesca Romana, Bellezza, Guido, Ricciuti, Biagio, Mandarano, Martina, Teti, Valeria, Siggillino, Annamaria, Reda, Maria Sole, Chiari, Rita, Pistola, Lorenza, Sidoni, Angelo, Minotti, Vincenzo, Roila, Fausto, Ludovini, Vienna
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2021
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8303258/
https://www.ncbi.nlm.nih.gov/pubmed/34209514
http://dx.doi.org/10.3390/genes12070992

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8303258/
https://www.ncbi.nlm.nih.gov/pubmed/34209514
http://dx.doi.org/10.3390/genes12070992

Ejemplares similares